163 related articles for article (PubMed ID: 11460306)
21. [Development of a Drug Delivery System for Cancer Immunotherapy].
Nakamura T
Yakugaku Zasshi; 2016; 136(11):1477-1484. PubMed ID: 27803478
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.
Taniyama T; Azuma I; Yamamura Y
Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor signaling in anti-cancer immunity.
Okamoto M; Sato M
J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
[TBL] [Abstract][Full Text] [Related]
24. Bacillus Calmette-Guérin cell-wall skeleton enhances the killing activity of cytotoxic lymphocyte-activated human dendritic cells transduced with the prostate-specific antigen gene.
Fujii R; Iwahashi M; Kikkawa K; Inagaki T; Kohjimoto Y; Ojima T; Mori T; Kuramoto T; Nishizawa S; Azuma I; Yamaue H; Shinka T; Hara I
BJU Int; 2009 Dec; 104(11):1766-73. PubMed ID: 20063450
[TBL] [Abstract][Full Text] [Related]
25. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
Miyazaki J; Kawai K; Kojima T; Oikawa T; Joraku A; Shimazui T; Nakaya A; Yano I; Nakamura T; Harashima H; Akaza H
BJU Int; 2011 Nov; 108(9):1520-6. PubMed ID: 21314815
[TBL] [Abstract][Full Text] [Related]
26. The restoration of suppressed T cell activities induced by 7,12-dimethylbenz[a]anthracene with an anti-tumor immunomodulator, BCG-cell wall skeleton.
Yamashita U; Ikegami R; Hamaoka T
Gan; 1982 Oct; 73(5):783-9. PubMed ID: 6219910
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticulation of BCG-CWS for application to bladder cancer therapy.
Nakamura T; Fukiage M; Higuchi M; Nakaya A; Yano I; Miyazaki J; Nishiyama H; Akaza H; Ito T; Hosokawa H; Nakayama T; Harashima H
J Control Release; 2014 Feb; 176():44-53. PubMed ID: 24389133
[TBL] [Abstract][Full Text] [Related]
28. Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro.
Kato T; Bilim V; Yuuki K; Naito S; Yamanobe T; Nagaoka A; Yano I; Akaza H; Tomita Y
Anticancer Res; 2010 Oct; 30(10):4089-96. PubMed ID: 21036724
[TBL] [Abstract][Full Text] [Related]
29. Successful regional immunotherapy with cell-wall skeletons of BCG and Nocardia rubra against autochthonous rat tumors.
Nagano N; Yasumoto K; Tanaka K; Ichinose Y; Yaita H; Nomoto K
Gan; 1982 Aug; 73(4):613-7. PubMed ID: 6759287
[TBL] [Abstract][Full Text] [Related]
30. Expanding the Potential of Neoantigen Vaccines: Harnessing Bacille Calmette-Guérin Cell-Wall-Based Nanoscale Adjuvants for Enhanced Cancer Immunotherapy.
Liu K; Peng J; Guo Y; Li Y; Qi X; Duan D; Li T; Li J; Niu Y; Han G; Zhao Y
ACS Nano; 2024 May; 18(18):11910-11920. PubMed ID: 38680054
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy of human lung cancer with BCG cell-wall skeleton.
Yasumoto K; Manabe H; Ueno M; Ohta M; Ueda H
Gan; 1976 Dec; 67(6):787-95. PubMed ID: 798710
[TBL] [Abstract][Full Text] [Related]
32. Morphological study on Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105).
Uenishi Y; Kawabe K; Nomura T; Nakai M; Sunagawa M
J Microbiol Methods; 2009 May; 77(2):139-44. PubMed ID: 19318051
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
[TBL] [Abstract][Full Text] [Related]
34. Human MD-1 homologue is a BCG-regulated gene product in monocytes: its identification by differential display.
Begum NA; Tsuji S; Nomura M; Shida K; Azuma I; Hayashi A; Matsumoto M; Seya T; Toyoshima K
Biochem Biophys Res Commun; 1999 Mar; 256(2):325-9. PubMed ID: 10079183
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of the patients with malignant pleural effusion with BCG cell-wall skeleton.
Yamamura Y; Ogura T; Yoshimoto T; Nishikawa H; Sakatani M
Gan; 1976 Oct; 67(5):669-77. PubMed ID: 797625
[TBL] [Abstract][Full Text] [Related]
36. Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation.
Kawamura N; Udagawa M; Fujita T; Sakurai T; Yaguchi T; Kawakami Y
Methods Mol Biol; 2014; 1139():145-53. PubMed ID: 24619677
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):831-4. PubMed ID: 374173
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
Yamamura Y; Sakatani M; Ogura T; Azuma I
Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
[TBL] [Abstract][Full Text] [Related]
39. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
Taniyama T; Azuma I; Aladin AA; Yamamura Y
Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
